Carnosine Eye Drops – The Key to Success for the Treatment of Cataracts

Can-C Eye drops represent a huge breakthrough in the treatment of cataracts. Until now the only way in which to treat cataracts has been to undergo cataract surgery. Although these days such surgery is very routine, quick (usually under 30 minutes duration) and requires very little sedation or recovery time, it is still none the less an invasive surgical procedure that inevitably carries with it a degree of risk.


But now, with Can-C Eye drops, you have a choice - a very real alternative to potentially risky, expensive surgery. Carnosine Eye Drops contain a unique formula that has been approved and patented by Innovative Vision Products, the company founded by Dr Mark Babizhayev from the Moscow Helmholtz Research Institute of Eye Diseases the original pioneer of this incredible product. Used daily, they have been proven to gently but effectively halt and even reverse the development of cataracts.


The key to their success lie in the fact that Can-C Eye drops contain carnosine. But these are no ordinary carnosine eyedrops. The Can-C eye drops formula is based upon a form of carnosine called N-acetylcarnosine which acts as a “carrier” of carnosine allowing it to be delivered directly into the aqueous humor of the eye (the fluid that surrounds the lens of the eye). This is critically important because it is in the lens of the eye that cataracts form.


Carnosine is effective against cataracts because it is known to be an important anti-glycation agent. The process of glycation involves sugar molecules bonding with proteins without the controlling action of enzymes.  It occurs naturally in the lens of the eye and the process is central to the formation of cataracts. The lens of the eye is essentially made up of water and proteins. The proteins are arranged in a very specific way that keeps the lens clear and allows light to pass through it. Glycation results in damage to these proteins and it is this that ultimately leads to the development of cataracts.


By preventing glycation, carnosine can stop the destructive process dead in its tracks thereby halting and reversing the formation of cataracts.


Carnosine also acts as a powerful anti-oxidant which provides protection against free radical damage- also significantly associated with the formation of cataracts.


The effects of Cataract Eye Drops are so dramatic that even after just 1 month changes are clearly visible. Damaged proteins are broken down and melt away - an effect known as "melting snow". The process starts at the periphery and gradually works towards the centre of the cataract with vision gradually improving all the time.


Can-C Eye drops - the real alternative to cataract surgery.

Resource - Carnosine Eye Drops – The Key to Success for the Treatment of Cataracts

What are Can-C Eyedrops?

Can-C Eyedrops have been specially formulated to treat cataracts - halting and even reversing the progression of the condition. This means that for the first time those suffering from senile cataracts have a real alternative to expensive surgery. These incredible ophthalmic eyedrops use a formula that has been approved and patented by the company that originally developed this most remarkable breakthrough in the treatment of cataracts - Innovative Vision Products.

Unlike surgery which is necessarily an invasive procedure that inevitably carries some risk, Can-C Eyedrops are non-invasive, gentle and effective.

The formula contains N-acetylcarnosine - a form of carnosine, the naturally occurring di-peptide of the amino-acids beta-alanine and l-histadine. Research has shown that carnosine plays an important role in the prevention of glycation. Glycation is the result of sugar molecules bonding to proteins without the controlling action of enzymes. The lens of the eye is made up mostly from water and proteins. These proteins are arranged in a very specific way that allows the lens to be kept clear and for light to pass through it. As glycation affects these proteins, it plays a crucial role in the formation of cataracts. By preventing glycation, carnosine works to prevent one of the root causes of cataracts.

Carnosine is also a powerful anti-oxidant. Anti-oxidants provide protection against free radical damage. This type of damage is also known to be heavily implicated in the formation of cataracts.

It´s important to note that not any form of carnosine eye drops can be used when treating cataracts. Research has demonstrated that it is the N-acetylcarnosine form of carnosine that is effective in this regard. This is because N-acetylcarnosine acts as a "carrier" of carnosine, allowing it to be delivered directly into the aqueous humor of the eye (the fluid surrounding the lens). What´s more, N-acetylcarnosine is also highly resistant to the enzyme carnosinase which works to break down carnosine.

Using its unique and patented formula, the safety profile of cataract eye drops is such that it allows N-acetylcarnosine to be administered directly into the eye and so enabling the prevention and reversal of the progression of cataracts without the need for surgery. 

Resources - What are Can-C Eyedrops?

The Scientific Evidence behind the use of N-acetylcarnosine Eyedrops

It’s all well and good stating that a product works, but what is really important is that statements such as these are backed up with scientific research that has been carried out using the most rigorous study protocols. Cataracts Drops meet this strict criterium.

The leading research in this area was carried out by Dr Mark Babizhayev and his team from the Moscow Helmholtz Research Institute of Eye Diseases. The researchers specifically examined the use of the ophthalmic formulation of N-acetylcarnosine (as found in Can-C Eyedrops) in cataract patients in order to establish whether or not using N-acetylcarnosine in such a way could actually obviate the need for these patients to undergo cataract surgery. The results were truly remarkable.

Dr Babizhayev and his colleagues established a controlled clinical trial that involved 110 eyes. The eyes were split into three groups:

• 60 eyes received the N-acetylcarnosine eye drop treatment twice a day
• 30 eyes formed a control group & were administered with a placebo eye drop
• 20 eyes received no treatment whatsoever

All of the eyes were evaluated at the start of the study and then at 2 monthly intervals over a total period of 6 months. Incredibly, at the end of the 6 month trial period a staggering 96% of the treated eyes showed improvement. But even more exciting was the fact that those eyes that showed the greatest improvements were in those affected by the most common form of cataracts - age related cataracts (often referred to as senile cataract).

To understand just how incredible these results were, you have to put them into some sort of context. Up until this point, it had been thought that the only way to effectively treat cataracts was by surgery. No non-invasive treatments were available. The clinical trial results confirmed that at last there really was an effective, alternative, non-surgical option available for the treatments of cataracts.

The study also revealed a remarkable new phenomenon - the "melting snow" effect. This was the name given to the clearly visible breakdown of the damaged proteins that cause cataracts - even after only 1 month of treatment. The reversal process began at the periphery with the affected lenses which gradually became more and more transparent. As the growth of the cataracts was reversed, so vision improved.

Dr Babizhayev is now the guiding light behind Innovative Vision Products Inc which has patented and approved the N-acetylcarnosine formulation found in Can-C Eyedrops.

Resources -  The Scientific Evidence behind the use of N-acetylcarnosine Eyedrops

How to use Can-C Eyedrops

Using Can-C Eyedrops to treat your cataracts could not be simpler. Simply apply two drops of Can-C Eyedrops twice a day into your affected eye(s). Although this might not seem like very much, there is no benefit to be gained from increasing this dose. If you are already using other eye medications, seek the advice of your ophthalmic physician before starting to use Can-C Eyedrops.

As with so many conditions, the sooner you start treating your cataracts the more effective your treatment will be. Therefore, it is recommended that you start using Can-C Eyedrops as soon as you have been diagnosed with cataracts.

It is also important to realise that just as senile cataracts do not suddenly appear overnight, Can-C Eyedrops cannot dissolve them that quickly either. Instead Can-C Eyedrops work gently but effectively over a period of time.

However, within one month of use, many people report measurable improvements in their condition. In order to gain maximum benefit, Can-C Eyedrops should be used as directed above for a period of at least 6 months. Even after your cataracts have been successfully treated, it is a good idea to carry on using Can-C Eyedrops in order to try and help prevent any reoccurrence of the problem - especially when you bear in mind senile cataracts are a condition intrinsically linked with aging. As a preventative measure, it is recommended that the dose be lowered to two drops once a day into each eye.

Fortunately, Can-C Eyedrops appear to be extremely well tolerated, with no real side effects. For most people, using Carnosine Drops should be an effective, easy to use, side effect free way of treating their cataracts. Rarely, a patient may experience some stinging. If this does happen, the situation should rectify itself with continued use. If not, then Can-C Eyedrops should no longer be used.

Another benefit of Cataract Drops that they can also be used by contact lens wearers. In fact, some people find that it makes wearing their contact lens more comfortable - particularly if they suffer from dryness and irritation that is sometimes associated with contact lens use. The active ingredient in Can-C Eyedrops, N-acetylcarnosine, may also reduce the build up of lactic acid in the eyes which means that contact lenses can safely be worn for longer.

Jacob - About the Author:

Jacob has the vast knowledge in health and doing research on eye drops from past 6 year. He is working with can c eye drops and write the articles on cataract eye drops, carnosine eye drops and senile cataract.

Article Taken From - How to use Can-C Eyedrops

Cataracts and Smoking

          Image by Thirteen Of Clubs

Quitting smoking is vitally important for our health and well being. That’s hardly news these days as public education into the increased health risks associated with smoking is well advanced. But whilst most of us are aware of the links between smoking and conditions such as heart disease, stroke, cancer and various lung diseases, not that many of us are familiar with the fact that smoking is associated with an increased risk of developing cataracts.

Whilst increasing age is undoubtedly the main risk factor when it comes to cataracts - which is why the most common form are known as senile cataract - the impact of smoking cannot be dismissed. Experts believe that cigarette smoking may in fact be responsible for up to 20 per cent of all cataracts. Research has shown that men who smoke more than a pack a day increase their risk for cataracts by a staggering 205 per cent! For female smokers, the risk of developing cataracts increases by a still very significant 63 per cent.

And whilst some of the risk factors for cataracts are things that you cannot either do anything about or would find hard to change such as getting older or being diabetic, maintaining a smoking habit is one of the most easily eliminated cataract risk factors.

Studies indicate that smoking is responsible for a two-pronged attack on the eyes that can lead to the development of cataracts in two ways. First of all, tobacco smoke contains harmful free radicals that directly assault the eye, potentially damaging lens proteins and the fiber cell membrane in the lens. Secondly, smoking reduces the body's levels of antioxidants and certain enzymes which may help to remove damaged proteins from the lens. With lower levels of these protective chemicals, damage to the lens proteins accumulates which manifests itself in the form of cataracts.

Unfortunately, while quitting smoking immediately may halt or even reverse some of the damage smoking can do to your body, you are still at substantially greater risk of cataract development than those who never smoked, even 20 years after kicking the habit.

Help though is at hand in the form of Can-C Eyedrops. With its powerful anti-oxidant formula using carnosine in the form of N-acetylcarnosine, Cataracts Drops boost anti-oxidant levels in the eyes which, combined with quitting smoking, can help to reduce your risk of cataract development or gently but effectively treat already formed cataracts.

Resources -  Cataracts and Smoking

Cataracts and Glycation

                         Image via WikipCataracts form in the lens of the eye - a biconvex structure that is essentially made up of water and proteins. These proteins are arranged in a very specific way that enables the lens to be kept clear and light to pass through it. However, if the proteins become damaged a cataract may start to form. And it is a process known as glycation that is a major culprit when it comes to protein damage.

Glycation is the reaction that occurs when simple sugar molecules such as fructose and glucose become attached (bind) to proteins (or lipid fats) without the controlling action of an enzyme. This process, also called non-enzymatic glycosylation, results in the formation of rogue molecules known as advanced glycation endproducts (AGEs). These AGEs interact with adjacent proteins (cross link) which results in impaired function, free radical formation and accelerated aging. AGEs are therefore linked to many age-related diseases and conditions including the development of senile cataracts.

Glycation is of particular concern to diabetics who already suffer from the effects of poor glucose control. Certainly, being diabetic increases your chances of developing cataracts due to increased glycation occurring.

It stands to reason then that if you can prevent and reverse glycation you are well on the way to helping to prevent and reverse cataracts. Fortunately, a chemical compound known as carnosine is capable of doing just that. Carnosine is a di-peptide made up from a combination of the amino-acids beta-alanine and l-histadine and has proven to be a very effective inhibitor of glycation. It works by competing with proteins for binding sites on sugar molecules. It is also thought to bind already produced AGEs so they get removed. In this way carnosine is capable of effectively preventing and reversing the development and growth of cataracts.

The trick has been to get carnosine to where it is needed most. And this where Can-C Eyedrops come in to play. The carnosine found in Can-C Eyedrops´ unique formula is specifically in the form of N-acetylcarnosine. N-acetylcarnosine acts as a "carrier" of carnosine which means that it can be delivered directly into the aqueous humor of the eye (the fluid surrounding the lens). N-acetylcarnosine is also highly resistant to the enzyme carnosinase - the natural enemy of carnosine because its action is to break down carnosine.

And the scientific evidence is clear. Clinical trials showed that after 6 months use of cataract eye drops 90% of patients had improved vision as the carnosine drops gently and effectively melted away their cataracts. 

Resource - Cataracts and Glycation

Cataracts and Free Radicals

Image by Getty Images via @daylife

Although age is the main risk factor when it comes to developing cataracts, experts are still not sure of the exact mechanisms that link cataract formation so closely with aging. In reality, there are probably a number of factors at play but two of the main contenders appear to be glycation and free radicals - both of which can damage the eye and lead to the development of cataracts. Here we concentrate on free radicals.

Free radicals (also known as oxidants) are the natural bi-products of metabolism. Because a free radical is missing an electron, it is a highly unstable, reactive chemical. In order to stabilise itself it needs to “grab” an electron from another chemical, usually from the nearest stable molecule. However, once the "attacked" molecule loses its electron, it then becomes a free radical itself, and a chain reaction begins.

In a healthy eye, the body is able remove free radicals by delivering "free radical scavengers" (anti-oxidants) to the eyes in the form of nutrients such as vitamin C and glutathione. But if there are not enough anti-oxidants available to combat the free radicals that are being produced, the numbers of free radicals increase and the reactive processes that they cause can be extremely harmful to nearly any type of cell in the body.

Unfortunately, as we age our supply of anti-oxidants naturally decreases, and damage from free radicals begins to accumulate. The formation of senile cataract is one of many destructive changes that can occur as a result.

One way to deal with the problem of aging and free radical damage is to boost the supply of anti-oxidants. And this is where Can-C Eyedrops come into their own. Carnosine Drops, as contained within Can C Eye Drops in the form of N-acetylcarnosine, is known to be a powerful anti-oxidant and as such works as an extremely important weapon in the fight against the free radical damage that can lead to cataracts.

Resource -  Cataracts and Free Radicals

Health Guide : Age Related Cataracts

                         Image via Wikipedia

For most people, cataracts are all part and parcel of the normal aging process. Indeed, the most common type of cataracts are those that develop as a result of the aging process. They are known as senile cataracts and it’s unusual for senile cataracts to be diagnosed in those under the age of 60. The cataracts develop as a result of changes in the protein structures within the lens of the eye. These changes usually happen very slowly and it can take years for cataracts to develop. Gradually, as the cataract grows, the lens becomes cloudy and vision is interfered with.

It is also unusual for cataracts to develop rapidly - although this not unheard of. Indeed, the development of cataracts is quite unpredictable. In some cases cataracts remain small, never progressing to the point where they affect vision and require treatment - but for most people treatment will eventually be needed. And even though cataracts commonly affect both eyes, it’s not uncommon for a cataract in one eye to grow more quickly than the one in the other eye.

And because cataracts tend to develop over such long periods of time, many patients are not diagnosed until their cataracts are quite well advanced. In fact, being diagnosed with senile cataract might come as a real surprise to you because in the early stage of their development you might not experience any vision problems at all. As such having cataracts might be something that is picked up during a routine eye examination rather than with you presenting with symptoms.

There can be no doubt that senile cataracts pose an enormous medical problem - not just to the individual sufferers who find that they may increasingly face difficulties in doing things that they were previously capable such as driving at night and reading, but also for the community as a whole.

Just look at the statistics in the US. By the time they have reached the age of 80, over half of all Americans will either have a cataract or have had cataract surgery. Currently, over 1.5 million cataract surgeries are performed in the US every year. This makes cataract surgery the most costly surgical expense in the US coming in at a staggering $3.2 billion p.a. Experts estimate that visual disability associated with cataracts accounts for over 8 million physician office visits a year! And as populations begin to age, with more and more people living for longer, these figures are set to rise.

Fortunately, Carnosine Drops now offer a viable alternative to the huge cost of treating cataracts surgically. Regular use with these amazing cataract eyedrops, gently but effectively breaks down the cataracts alleviating the need for surgery.

Resource - Health Guide : Age Related Cataracts